Darinaparson
SGL2001b
Phase 2 small_molecule active
Quick answer
Darinaparson for Multiple Myeloma is a Phase 2 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alaunos Therapeutics
- Indication
- Multiple Myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active